The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies

References

• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabet Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Federation ID. IDF Diabetes Atlas. 10th ed. DiabetesAtlas; 2021.
   Google Scholar
• Akdağ M, Özçelik AB, Demir Y, Beydemir Ş. Design, synthesis, and aldose reductase inhibitory effect of some novel carboxylic acid derivatives bearing 2-substituted-6-aryloxo-pyridazinone moiety. J Mol Struct. 2022;1258:132675. doi:10.1016/j.molstruc.2022.132675
   Web of Science ®Google Scholar
• Sever B, Altıntop MD, Demir Y, et al. Identification of a new class of potent aldose reductase inhibitors: design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines. Chem. Biol. Interact. 2021;345:109576. doi:10.1016/j.cbi.2021.109576
   PubMed Web of Science ®Google Scholar
• Koye DN, Shaw JE, Reid CM, Atkins RC, Reutens AT, Magliano DJ. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Diabet Med. 2017;34(7):887–901. doi:10.1111/dme.13324
   PubMed Web of Science ®Google Scholar
• Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl 1):3–15. doi:10.1111/dom.14007
   PubMed Web of Science ®Google Scholar
• Cheng HT, Xu X, Lim PS, Hung KY. Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015. Diabetes Care. 2021;44(1):89–97. doi:10.2337/dc20-1913
   PubMed Web of Science ®Google Scholar
• Sever B, Altıntop MD, Demir Y, et al. An extensive research on aldose reductase inhibitory effects of new 4h-1,2,4-triazole derivatives. J Mol Struct. 2021;1224:129446. doi:10.1016/j.molstruc.2020.129446
   Web of Science ®Google Scholar
• Demir Y, Ceylan H, Türkeş C, Beydemir Ş. Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes. J Biomol Struct Dyn. 2022;40(22):12008–12021. doi:10.1080/07391102.2021.1967195
   PubMed Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045. doi:10.2215/CJN.11491116
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of sglt2 inhibitors. Nat Rev Nephrol. 2021;17(5):319–334. doi:10.1038/s41581-021-00393-8
   PubMed Web of Science ®Google Scholar
• Tuttle KR, Agarwal R, Alpers CE, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248–260. doi:10.1016/j.kint.2022.05.012
   PubMed Web of Science ®Google Scholar
• Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107(4):689–705. doi:10.1016/j.mcna.2023.03.004
   PubMed Web of Science ®Google Scholar
• Sever B, Altıntop MD, Demir Y, Akalın Çiftçi G, Beydemir Ş, Özdemir A. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds. Bioorg. Chem. 2020;102:104110. doi:10.1016/j.bioorg.2020.104110
   PubMed Web of Science ®Google Scholar
• Demir Y, Tokalı FS, Kalay E, et al. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors. Molecular Diversity. 2023;27(4):1713–1733. doi:10.1007/s11030-022-10526-1
   PubMed Web of Science ®Google Scholar
• Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449. doi:10.1155/2021/1497449
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016;12(1):13–26. doi:10.1038/nrneph.2015.175
   PubMed Web of Science ®Google Scholar
• Veiras LC, Bernstein EA, Cao D, et al. Tubular il-1beta induces salt sensitivity in diabetes by activating renal macrophages. Circ Res. 2022;131:59–73. doi:10.1161/CIRCRESAHA.121.320239
   PubMed Web of Science ®Google Scholar
• Jiang WJ, Xu CT, Du CL, et al. Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy. Theranostics. 2022;12:324–339. doi:10.7150/thno.63735
   PubMed Web of Science ®Google Scholar
• Tokalı FS, Demir Y, Türkeş C, Dinçer B, Beydemir Ş. Novel acetic acid derivatives containing quinazolin-4(3 H)-one ring: synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Drug Dev. Res. 2023;84(2):275–295. doi:10.1002/ddr.22031
   PubMed Web of Science ®Google Scholar
• Ertano BY, Demir Y, Nural Y, Erdoğan O. Investigation of the effect of acylthiourea derivatives on diabetes-associated enzymes. ChemistrySelect. 2022;7(46):e202204149. doi:10.1002/slct.202204149
   Web of Science ®Google Scholar
• Zheng Z, Zheng F. Immune cells and inflammation in diabetic nephropathy. J Diabetes Res. 2016;2016:1841690. doi:10.1155/2016/1841690
   PubMed Web of Science ®Google Scholar
• Kong L, Andrikopoulos S, MacIsaac RJ, et al. Role of the adaptive immune system in diabetic kidney disease. J Diabetes Investig. 2022;13:213–226. doi:10.1111/jdi.13725
   PubMed Web of Science ®Google Scholar
• Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004;65(1):116–128. doi:10.1111/j.1523-1755.2004.00367.x
   PubMed Web of Science ®Google Scholar
• Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant. 2004;19(12):2987–2996. doi:10.1093/ndt/gfh441
   PubMed Web of Science ®Google Scholar
• Ma T, Li X, Zhu Y, et al. Excessive activation of notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis. Front Immunol. 2022;13:835879. doi:10.3389/fimmu.2022.835879
   PubMed Web of Science ®Google Scholar
• Kim SM, Lee SH, Lee A, et al. Targeting t helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression. Transl Res. 2015;166:375–383. doi:10.1016/j.trsl.2015.04.013
   PubMed Web of Science ®Google Scholar
• Lavoz C, Matus YS, Orejudo M, et al. Interleukin-17a blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. Kidney Int. 2019;95(6):1418–1432. doi:10.1016/j.kint.2018.12.031
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240–273. doi:10.1128/CMR.00046-08
   PubMed Web of Science ®Google Scholar
• McComb S, Thiriot A, Akache B, Krishnan L, Stark F. Introduction to the immune system. Methods Mol Biol. 2019;2024:1–24.
   PubMedGoogle Scholar
• Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 2020;16(4):206–222. doi:10.1038/s41581-019-0234-4
   PubMed Web of Science ®Google Scholar
• Fortpied J, Vertommen D, Van Schaftingen E. Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev. 2010;26(4):254–260. doi:10.1002/dmrr.1079
   PubMed Web of Science ®Google Scholar
• Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017;13(5):311–318. doi:10.1038/nrneph.2017.31
   PubMed Web of Science ®Google Scholar
• Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, Lee SH. Aberrant recruitment and activation of t cells in diabetic nephropathy. Am J Nephrol. 2012;35(2):164–174. doi:10.1159/000334928
   PubMed Web of Science ®Google Scholar
• Ryba-Stanislawowska M, Skrzypkowska M, Mysliwiec M, Mysliwska J. Loss of the balance between cd4(+)foxp3(+) regulatory t cells and cd4(+)il17a(+) th17 cells in patients with type 1 diabetes. Hum Immunol. 2013;74:701–707. doi:10.1016/j.humimm.2013.01.024
   PubMed Web of Science ®Google Scholar
• Klessens CQF, Zandbergen M, Wolterbeek R, et al. Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrol Dial Transplant. 2017;32:1322–1329. doi:10.1093/ndt/gfw260
   PubMed Web of Science ®Google Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144–158. doi:10.1038/s41581-019-0110-2
   PubMed Web of Science ®Google Scholar
• Li HD, You YK, Shao BY, et al. Roles and crosstalks of macrophages in diabetic nephropathy. Front Immunol. 2022;13:1015142. doi:10.3389/fimmu.2022.1015142
   PubMed Web of Science ®Google Scholar
• Lv LL, Tang PM, Li CJ, et al. The pattern recognition receptor, mincle, is essential for maintaining the m1 macrophage phenotype in acute renal inflammation. Kidney Int. 2017;91:587–602. doi:10.1016/j.kint.2016.10.020
   PubMed Web of Science ®Google Scholar
• Meng XM, Tang PM, Li J, Lan HY. Macrophage phenotype in kidney injury and repair. Kidney Dis. 2015;1:138–146. doi:10.1159/000431214
   Google Scholar
• Zhang X, Yang Y, Zhao Y. Macrophage phenotype and its relationship with renal function in human diabetic nephropathy. PLoS One. 2019;14(9):e0221991. doi:10.1371/journal.pone.0221991
   PubMed Web of Science ®Google Scholar
• Ji L, Chen Y, Wang H, et al. Overexpression of sirt6 promotes m2 macrophage transformation, alleviating renal injury in diabetic nephropathy. Int J Oncol. 2019;55(1):103–115. doi:10.3892/ijo.2019.4800
   PubMed Web of Science ®Google Scholar
• Williams BM, Cliff CL, Lee K, Squires PE, Hills CE. The role of the nlrp3 inflammasome in mediating glomerular and tubular injury in diabetic nephropathy. Front Physiol. 2022;13:907504. doi:10.3389/fphys.2022.907504
   PubMed Web of Science ®Google Scholar
• Hou Q, Kan S, Wang Z, et al. Inhibition of hdac6 with cay10603 ameliorates diabetic kidney disease by suppressing nlrp3 inflammasome. Front Pharmacol. 2022;13:938391. doi:10.3389/fphar.2022.938391
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen J, Li YY, Xia LL, Wu YG. Bruton’s tyrosine kinase regulates macrophage‑induced inflammation in the diabetic kidney via nlrp3 inflammasome activation. Int J Mol Med. 2021;47(4):48. doi:10.3892/ijmm.2021.4881
   PubMedGoogle Scholar
• Fan Z, Wang Y, Xu X, Wu Y. Inhibitor of bruton’s tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators’ production in high glucose-induced macrophages. Int Immunopharmacol. 2018;58:145–153. doi:10.1016/j.intimp.2018.03.019
   PubMed Web of Science ®Google Scholar
• Choi SY, Lim SW, Salimi S, et al. Tonicity-responsive enhancer-binding protein mediates hyperglycemia-induced inflammation and vascular and renal injury. J Am Soc Nephrol. 2018;29(2):492–504. doi:10.1681/ASN.2017070718
   PubMed Web of Science ®Google Scholar
• Bus P, Pierneef L, Bor R, et al. Apolipoprotein c-i plays a role in the pathogenesis of glomerulosclerosis. J Pathol. 2017;241(5):589–599. doi:10.1002/path.4859
   PubMed Web of Science ®Google Scholar
• Nitta T, Kanoh H, Inamori KI, Suzuki A, Takahashi T, Inokuchi JI. Globo-series glycosphingolipids enhance toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy. Glycobiology. 2019;29:260–268. doi:10.1093/glycob/cwy105
   PubMed Web of Science ®Google Scholar
• Ma Y, Cai F, Huang X, et al. Mannose-binding lectin activates the nuclear factor-kappab and renal inflammation in the progression of diabetic nephropathy. FASEB J. 2022;36:e22227. doi:10.1096/fj.202101852R
   PubMed Web of Science ®Google Scholar
• Menzies RI, Booth JWR, Mullins JJ, et al. Hyperglycemia-induced renal p2x7 receptor activation enhances diabetes-related injury. EBioMedicine. 2017;19:73–83. doi:10.1016/j.ebiom.2017.04.011
   PubMed Web of Science ®Google Scholar
• Goldberg R, Rubinstein AM, Gil N, et al. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy. Diabetes. 2014;63(12):4302–4313. doi:10.2337/db14-0001
   PubMed Web of Science ®Google Scholar
• Yu S, Cheng Y, Li B, et al. M1 macrophages accelerate renal glomerular endothelial cell senescence through reactive oxygen species accumulation in streptozotocin-induced diabetic mice. Int Immunopharmacol. 2020;81:106294. doi:10.1016/j.intimp.2020.106294
   PubMed Web of Science ®Google Scholar
• Nishad R, Mukhi D, Kethavath S, et al. Podocyte derived tnf-alpha mediates monocyte differentiation and contributes to glomerular injury. FASEB J. 2022;36:e22622.
   PubMed Web of Science ®Google Scholar
• Haruhara K, Suzuki T, Wakui H, et al. Deficiency of the kidney tubular angiotensin ii type1 receptor-associated protein atrap exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization. Kidney Int. 2022;101(5):912–928. doi:10.1016/j.kint.2022.01.031
   PubMed Web of Science ®Google Scholar
• Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the nf-kappab/tnf-alpha pathway. Mol Metab. 2019;23:24–36. doi:10.1016/j.molmet.2019.02.007
   PubMed Web of Science ®Google Scholar
• Ma Y, Chen Y, Xu H, Du N. The influence of angiopoietin-like protein 3 on macrophages polarization and its effect on the podocyte emt in diabetic nephropathy. Front Immunol. 2023;14:1228399. doi:10.3389/fimmu.2023.1228399
   PubMedGoogle Scholar
• Lv LL, Feng Y, Wu M, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes m1 macrophage activation in kidney injury. Cell Death Differ. 2020;27:210–226. doi:10.1038/s41418-019-0349-y
   PubMed Web of Science ®Google Scholar
• Ding X, Jing N, Shen A, et al. Mir-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating a20. J Endocrinol Invest. 2021;44(6):1175–1184. doi:10.1007/s40618-020-01401-7
   PubMed Web of Science ®Google Scholar
• Jia Y, Chen J, Zheng Z, et al. Tubular epithelial cell-derived extracellular vesicles induce macrophage glycolysis by stabilizing hif-1alpha in diabetic kidney disease. Mol Med. 2022;28(1):95. doi:10.1186/s10020-022-00525-1
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen J, Zhu W, Qi XM, Wu YG. Exosomal miR −7002-5p derived from high glucose-induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b. FASEB J. 2022;36(9):e22501. doi:10.1096/fj.202200550RR
   PubMed Web of Science ®Google Scholar
• Liu Y, Li X, Zhao M, et al. Macrophage-derived exosomes promote activation of nlrp3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy. Life Sci. 2023;330:121991. doi:10.1016/j.lfs.2023.121991
   PubMed Web of Science ®Google Scholar
• Liu JL, Zhang L, Huang Y, et al. Epsin1-mediated exosomal sorting of dll4 modulates the tubular-macrophage crosstalk in diabetic nephropathy. Mol Ther. 2023;31(5):1451–1467. doi:10.1016/j.ymthe.2023.03.027
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun W, Li R, Liu Y. miRNA-93-5p in exosomes derived from m2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting toll-like receptor 4. Bioengineered. 2022;13(3):7683–7696. doi:10.1080/21655979.2021.2023794
   PubMed Web of Science ®Google Scholar
• Huang H, Liu H, Tang J, et al. M2 macrophage-derived exosomal miR −25-3p improves high glucose-induced podocytes injury through activation autophagy via inhibiting DUSP1 expression. IUBMB Life. 2020;72(12):2651–2662. doi:10.1002/iub.2393
   PubMed Web of Science ®Google Scholar
• Kaminski H, Couzi L, Eberl M. Unconventional t cells and kidney disease. Nat Rev Nephrol. 2021;17(12):795–813. doi:10.1038/s41581-021-00466-8
   PubMed Web of Science ®Google Scholar
• Casey KA, Fraser KA, Schenkel JM, et al. Antigen-independent differentiation and maintenance of effector-like resident memory t cells in tissues. J Immunol. 2012;188(10):4866–4875. doi:10.4049/jimmunol.1200402
   PubMed Web of Science ®Google Scholar
• Forbes JM, McCarthy DA, Kassianos AJ, et al. T-cell expression and release of kidney injury molecule-1 in response to glucose variations initiates kidney injury in early diabetes. Diabetes. 2021;70(8):1754–1766. doi:10.2337/db20-1081
   PubMed Web of Science ®Google Scholar
• Zhang N, Tai J, Qu Z, et al. Increased CD4 + CXCR5 + T follicular helper cells in diabetic nephropathy. Autoimmunity. 2016;49(6):405–413. doi:10.1080/08916934.2016.1196677
   PubMed Web of Science ®Google Scholar
• Lei L, Cui L, Mao Y, et al. Augmented cd25 and cd69 expression on circulating cd8+ t cells in type 2 diabetes mellitus with albuminuria. Diabetes Metab. 2017;43(4):382–384. doi:10.1016/j.diabet.2016.10.002
   PubMed Web of Science ®Google Scholar
• Lampropoulou IT, Stangou M, Sarafidis P, et al. Tnf-alpha pathway and t-cell immunity are activated early during the development of diabetic nephropathy in type ii diabetes mellitus. Clin Immunol. 2020;215:108423. doi:10.1016/j.clim.2020.108423
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhong X, Ni HF, et al. Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy. J Transl Med. 2021;19:355. doi:10.1186/s12967-021-03030-x
   PubMed Web of Science ®Google Scholar
• Jin J, Wang L, Liu Y, et al. Depiction of immune heterogeneity of peripheral blood from patients with type ii diabetic nephropathy based on mass cytometry. Front Endocrinol. 2022;13:1018608. doi:10.3389/fendo.2022.1018608
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10(9):493–503. doi:10.1038/nrneph.2014.114
   PubMed Web of Science ®Google Scholar
• Gharaie Fathabad S, Kurzhagen JT, Sadasivam M, et al. T lymphocytes in acute kidney injury and repair. Semin Nephrol. 2020;40(2):114–125. doi:10.1016/j.semnephrol.2020.01.003
   PubMed Web of Science ®Google Scholar
• Liu Y, Lv Y, Zhang T, et al. T cells and their products in diabetic kidney disease. Front Immunol. 2023;14:1084448. doi:10.3389/fimmu.2023.1084448
   PubMed Web of Science ®Google Scholar
• Nastase MV, Zeng-Brouwers J, Beckmann J, et al. Biglycan, a novel trigger of th1 and th17 cell recruitment into the kidney. Matrix Biol. 2018;68-69:293–317. doi:10.1016/j.matbio.2017.12.002
   PubMed Web of Science ®Google Scholar
• Yu H, Cui S, Mei Y, et al. Mesangial cells exhibit features of antigen-presenting cells and activate cd4+ t cell responses. J Immunol Res. 2019;2019:2121849. doi:10.1155/2019/2121849
   PubMed Web of Science ®Google Scholar
• Li L, Tang W, Zhang Y, et al. Targeting tissue-resident memory cd8(+) t cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis. Mol Ther. 2022;30(8):2746–2759. doi:10.1016/j.ymthe.2022.04.024
   PubMed Web of Science ®Google Scholar
• Kuo HL, Huang CC, Lin TY, Lin CY. Il-17 and cd40 ligand synergistically stimulate the chronicity of diabetic nephropathy. Nephrol Dial Transplant. 2018;33(2):248–256. doi:10.1093/ndt/gfw397
   PubMed Web of Science ®Google Scholar
• Balakumar P, Reddy J, Singh M. Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy? Mol Cell Biochem. 2009;330(1–2):187–192. doi:10.1007/s11010-009-0132-3
   PubMed Web of Science ®Google Scholar
• Zheng JM, Yao GH, Cheng Z, Wang R, Liu ZH. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease. Diabetologia. 2012;55(3):801–811. doi:10.1007/s00125-011-2391-2
   PubMed Web of Science ®Google Scholar
• de Morais RB, Do Couto Muniz VP, Nunes Costa E, et al. Mast cell population in the development of diabetic nephropathy: effects of renin angiotensin system inhibition. Biomed Pharmacother. 2018;107:1115–1118. doi:10.1016/j.biopha.2018.08.066
   PubMed Web of Science ®Google Scholar
• Yin DD, Luo JH, Zhao ZY, Liao YJ, Li Y. Tranilast prevents renal interstitial fibrosis by blocking mast cell infiltration in a rat model of diabetic kidney disease. Mol Med Rep. 2018;17(5):7356–7364. doi:10.3892/mmr.2018.8776
   PubMed Web of Science ®Google Scholar
• Fan Z, Gao Y, Jiang N, Zhang F, Liu S, Li Q. Immune-related serpina3 as a biomarker involved in diabetic nephropathy renal tubular injury. Front Immunol. 2022;13:979995. doi:10.3389/fimmu.2022.979995
   PubMed Web of Science ®Google Scholar
• LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570–1580. doi:10.1182/blood-2008-02-078071
   PubMed Web of Science ®Google Scholar
• Nicoloff G, Blazhev A, Petrova C, Christova P. Circulating immune complexes among diabetic children. Clin Dev Immunol. 2004;11(1):61–66. doi:10.1080/10446670410001670517
   PubMedGoogle Scholar
• Xiao X, Ma B, Dong B, et al. Cellular and humoral immune responses in the early stages of diabetic nephropathy in nod mice. J Autoimmun. 2009;32(2):85–93. doi:10.1016/j.jaut.2008.12.003
   PubMed Web of Science ®Google Scholar
• Abdelsamie SA, Li Y, Huang Y, et al. Oxidized LDL immune complexes stimulate collagen iv production in mesangial cells via fc gamma receptors I and III. Clin Immunol. 2011;139(3):258–266. doi:10.1016/j.clim.2011.01.016
   PubMed Web of Science ®Google Scholar
• Smith MJ, Simmons KM, Cambier JC. B cells in type 1 diabetes mellitus and diabetic kidney disease. Nat Rev Nephrol. 2017;13(11):712–720. doi:10.1038/nrneph.2017.138
   PubMed Web of Science ®Google Scholar
• Li T, Yu Z, Qu Z, Zhang N, Crew R, Jiang Y. Decreased number of cd19(+)cd24(hi)cd38(hi) regulatory b cells in diabetic nephropathy. Mol Immunol. 2019;112:233–239. doi:10.1016/j.molimm.2019.05.014
   PubMed Web of Science ®Google Scholar
• Huang W, Huang J, Liu Q, et al. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol (Oxf). 2015;82:229–233. doi:10.1111/cen.12576
   PubMed Web of Science ®Google Scholar
• Ciray H, Aksoy AH, Ulu N, Cizmecioglu A, Gaipov A, Solak Y. Nephropathy, but not angiographically proven retinopathy, is associated with neutrophil to lymphocyte ratio in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2015;123(05):267–271. doi:10.1055/s-0035-1547257
   PubMedGoogle Scholar
• Wang Y, Peng X, Hu J, et al. Low-dose colchicine in type 2 diabetes with microalbuminuria: a double-blind randomized clinical trial. J Diabetes. 2021;13(10):827–836. doi:10.1111/1753-0407.13174
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Stadler S, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009;184(2):205–213. doi:10.1083/jcb.200806072
   PubMed Web of Science ®Google Scholar
• Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191(3):677–691. doi:10.1083/jcb.201006052
   PubMed Web of Science ®Google Scholar
• Zheng F, Ma L, Li X, et al. Neutrophil extracellular traps induce glomerular endothelial cell dysfunction and pyroptosis in diabetic kidney disease. Diabetes. 2022;71(12):2739–2750. doi:10.2337/db22-0153
   PubMed Web of Science ®Google Scholar
• Gupta A, Singh K, Fatima S, et al. Neutrophil extracellular traps promote nlrp3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease. Nutrients;2022. 14. doi:10.3390/nu15010014
   PubMed Web of Science ®Google Scholar
• Kunder M, Lakshmaiah V, Moideen Kutty AV. Selective decrease in alpha1-antitrypsin levels in diabetic retinopathy: could the levels of it be playing a role in the pathophysiology of diabetic retinopathy? Indian J Med Res. 2022;156:104–110.
   PubMed Web of Science ®Google Scholar
• Schuijs MJ, Halim TYF. Group 2 innate lymphocytes at the interface between innate and adaptive immunity. Ann N Y Acad Sci. 2018;1417(1):87–103. doi:10.1111/nyas.13604
   PubMed Web of Science ®Google Scholar
• Zhu J. T helper 2 (th2) cell differentiation, type 2 innate lymphoid cell (ilc2) development and regulation of interleukin-4 (il-4) and il-13 production. Cytokine. 2015;75(1):14–24. doi:10.1016/j.cyto.2015.05.010
   PubMed Web of Science ®Google Scholar
• Doherty TA, Broide DH. Group 2 innate lymphoid cells: new players in human allergic diseases. J Investig Allergol Clin Immunol. 2015;25:1–11.
   PubMed Web of Science ®Google Scholar
• Mikami Y, Takada Y, Hagihara Y, Kanai T. Innate lymphoid cells in organ fibrosis. Cytokine Growth Factor Rev. 2018;42:27–36. doi:10.1016/j.cytogfr.2018.07.002
   PubMed Web of Science ®Google Scholar
• Lu P, Ji X, Wan J, Xu H. Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy. Scand J Immunol. 2018;87(2):99–107. doi:10.1111/sji.12637
   PubMed Web of Science ®Google Scholar
• Liu C, Qin L, Ding J, et al. Group 2 innate lymphoid cells participate in renal fibrosis in diabetic kidney disease partly via TGF-β1 signal pathway. J Diabetes Res. 2019;2019:8512028. doi:10.1155/2019/8512028
   PubMed Web of Science ®Google Scholar
• Potter SS. Single-cell RNA sequencing for the study of development, physiology and disease. Nat Rev Nephrol. 2018;14(8):479–492. doi:10.1038/s41581-018-0021-7
   PubMed Web of Science ®Google Scholar
• Chen J, Luo P, Wang C, et al.Integrated single-cell transcriptomics and proteomics reveal cellular-specific responses and microenvironment remodeling in aristolochic acid nephropathy. JCI Insight. 2022;(16):7. doi:10.1172/jci.insight.157360
   Web of Science ®Google Scholar
• Wu H, Kirita Y, Donnelly EL, Humphreys BD. Advantages of single-nucleus over single-cell RNA sequencing of adult kidney: rare cell types and novel cell states revealed in fibrosis. J Am Soc Nephrol. 2019;30(1):23–32. doi:10.1681/ASN.2018090912
   PubMed Web of Science ®Google Scholar
• Wilson PC, Wu H, Kirita Y, et al. The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A. 2019;116(39):19619–19625. doi:10.1073/pnas.1908706116
   PubMed Web of Science ®Google Scholar
• Fu J, Akat KM, Sun Z, et al. Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease. J Am Soc Nephrol. 2019;30(4):533–545. doi:10.1681/ASN.2018090896
   PubMed Web of Science ®Google Scholar
• Fu J, Sun Z, Wang X, et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022;102(6):1291–1304. doi:10.1016/j.kint.2022.08.026
   PubMed Web of Science ®Google Scholar
• Wu C, Tao Y, Li N, et al. Prediction of cellular targets in diabetic kidney diseases with single-cell transcriptomic analysis of db/db mouse kidneys. J Cell Commun Signal. 2023;17(1):169–188. doi:10.1007/s12079-022-00685-z
   PubMed Web of Science ®Google Scholar
• Wu H, Humphreys BD. Immune cell heterogeneity in a mouse model of diabetic kidney disease. Kidney Int. 2022;102(6):1215–1216. doi:10.1016/j.kint.2022.09.007
   PubMed Web of Science ®Google Scholar
• Gottesfeld JM, Carey MF. Introduction to the thematic minireview series: chromatin and transcription. J Biol Chem. 2018;293(36):13775–13777. doi:10.1074/jbc.TM118.004544
   PubMed Web of Science ®Google Scholar
• Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10(12):1213–1218. doi:10.1038/nmeth.2688
   PubMed Web of Science ®Google Scholar
• Kuppe C, Perales-Paton J, Saez-Rodriguez J, Kramann R. Experimental and computational technologies to dissect the kidney at the single-cell level. Nephrol Dial Transplant. 2022;37(4):628–637. doi:10.1093/ndt/gfaa233
   PubMed Web of Science ®Google Scholar
• Stoeckius M, Hafemeister C, Stephenson W, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14(9):865–868. doi:10.1038/nmeth.4380
   PubMed Web of Science ®Google Scholar
• Yao X, Shen H, Cao F, et al. Bioinformatics analysis reveals crosstalk among platelets, immune cells, and the glomerulus that may play an important role in the development of diabetic nephropathy. Front Med. 2021;8:657918. doi:10.3389/fmed.2021.657918
   Web of Science ®Google Scholar
• Zhou W, Liu Y, Hu Q, Zhou J, Lin H. The landscape of immune cell infiltration in the glomerulus of diabetic nephropathy: evidence based on bioinformatics. BMC Nephrol. 2022;23(1):303. doi:10.1186/s12882-022-02906-4
   PubMed Web of Science ®Google Scholar
• Ming J, Sana S, Deng X. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy. Front Endocrinol. 2022;13:978601. doi:10.3389/fendo.2022.978601
   PubMed Web of Science ®Google Scholar
• Fu S, Cheng Y, Wang X, et al. Identification of diagnostic gene biomarkers and immune infiltration in patients with diabetic kidney disease using machine learning strategies and bioinformatic analysis. Front Med. 2022;9:918657. doi:10.3389/fmed.2022.918657
   Web of Science ®Google Scholar
• Jia Y, Xu H, Yu Q, Tan L, Xiong Z. Identification and verification of vascular cell adhesion protein 1 as an immune-related hub gene associated with the tubulointerstitial injury in diabetic kidney disease. Bioengineered. 2021;12(1):6655–6673. doi:10.1080/21655979.2021.1976540
   PubMed Web of Science ®Google Scholar
• Ye Z, Zhang Y, Huang N, Chen S, Wu X, Li L. Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy. Front Immunol. 2022;13:1006137. doi:10.3389/fimmu.2022.1006137
   PubMed Web of Science ®Google Scholar
• Li T, Shen K, Li J, Leung SWS, Zhu T, Shi Y. Glomerular endothelial cells are the coordinator in the development of diabetic nephropathy. Front Med. 2021;8:655639. doi:10.3389/fmed.2021.655639
   Web of Science ®Google Scholar
• Wei Y, Gao X, Li A, Liang M, Jiang Z. Single-nucleus transcriptomic analysis reveals important cell cross-talk in diabetic kidney disease. Front Med. 2021;8:657956. doi:10.3389/fmed.2021.657956
   Web of Science ®Google Scholar
• Mkm M, Yung S, Chan TM. Mtor inhibition and kidney diseases. Transplantation. 2018;102:S32–S40. doi:10.1097/TP.0000000000001729
   PubMedGoogle Scholar
• Lu X, Li L, Suo L, et al. Single-cell RNA sequencing profiles identify important pathophysiologic factors in the progression of diabetic nephropathy. Front Cell Dev Biol. 2022;10:798316. doi:10.3389/fcell.2022.798316
   PubMed Web of Science ®Google Scholar
• Sur S, Nguyen M, Boada P, Sigdel TK, Sollinger H, Sarwal MM. Fcer1: a novel molecule implicated in the progression of human diabetic kidney disease. Front Immunol. 2021;12:769972. doi:10.3389/fimmu.2021.769972
   PubMed Web of Science ®Google Scholar
• Yu K, Li D, Xu F, et al. Ido1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration. Int Immunopharmacol. 2021;94:107446. doi:10.1016/j.intimp.2021.107446
   PubMed Web of Science ®Google Scholar
• Xu Q, Li B, Wang Y, et al. Identification of vcan as hub gene for diabetic kidney disease immune injury using integrated bioinformatics analysis. Front Physiol. 2021;12:651690. doi:10.3389/fphys.2021.651690
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang Z, Zhou L, et al. Identification of ccl19 as a novel immune-related biomarker in diabetic nephropathy. Front Genet. 2022;13:830437. doi:10.3389/fgene.2022.830437
   PubMed Web of Science ®Google Scholar
• Li X, Liu J, Zeng M, et al. Gbp2 promotes m1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy. Front Immunol. 2023;14:1127612. doi:10.3389/fimmu.2023.1127612
   PubMed Web of Science ®Google Scholar
• Zhou M, Lu F, Jiang L, et al. Decoding the intercellular cross-talking between immune cells and renal innate cells in diabetic kidney disease by bioinformatics. J Inflamm Res. 2023;16:3049–3062. doi:10.2147/JIR.S409017
   PubMed Web of Science ®Google Scholar
• Li C, Su F, Zhang L, et al. Identifying potential diagnostic genes for diabetic nephropathy based on hypoxia and immune status. J Inflamm Res. 2021;14:6871–6891. doi:10.2147/JIR.S341032
   PubMed Web of Science ®Google Scholar
• Lu K, Wang L, Fu Y, Li G, Zhang X, Cao M. Bioinformatics analysis identifies immune-related gene signatures and subtypes in diabetic nephropathy. Front Endocrinol. 2022;13:1048139. doi:10.3389/fendo.2022.1048139
   PubMed Web of Science ®Google Scholar
• Zhang X, Chao P, Zhang L, et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198. doi:10.3389/fimmu.2023.1030198
   PubMed Web of Science ®Google Scholar
• Xu M, Zhou H, Hu P, et al. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by wgcna and machine learning. Front Immunol. 2023;14:1084531. doi:10.3389/fimmu.2023.1084531
   PubMed Web of Science ®Google Scholar
• Chen J, Luo SF, Yuan X, et al. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (wgcna). J Cell Biochem. 2022;123(2):481–492. doi:10.1002/jcb.30195
   PubMed Web of Science ®Google Scholar
• Ma J, Li C, Liu T, et al. Identification of markers for diagnosis and treatment of diabetic kidney disease based on the ferroptosis and immune. Oxid Med Cell Longev. 2022;2022:9957172. doi:10.1155/2022/9957172
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao M, Zhang Y. Identification of fibronectin 1 (fn1) and complement component 3 (c3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis. Bioengineered. 2021;12(1):5386–5401. doi:10.1080/21655979.2021.1960766
   PubMed Web of Science ®Google Scholar
• Han H, Chen Y, Yang H, et al. Identification and verification of diagnostic biomarkers for glomerular injury in diabetic nephropathy based on machine learning algorithms. Front Endocrinol. 2022;13:876960. doi:10.3389/fendo.2022.876960
   PubMed Web of Science ®Google Scholar
• Zhang H, Hu J, Zhu J, Li Q, Fang L. Machine learning-based metabolism-related genes signature and immune infiltration landscape in diabetic nephropathy. Front Endocrinol. 2022;13:1026938. doi:10.3389/fendo.2022.1026938
   PubMed Web of Science ®Google Scholar
• Zhou H, Mu L, Yang Z, Shi Y. Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy. Front Immunol. 2023;14:1113212. doi:10.3389/fimmu.2023.1113212
   PubMed Web of Science ®Google Scholar